Marker Test Diagnostics Company Profile

05:43 EDT 19th March 2019 | BioPortfolio

Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative oral marker for the drug testing market. Marker Test Diagnostics is currently conducting research studies in the field of addiction and sport and collaborates with the Olympic Doping Laboratory at the UCLA and a renowned research university. For more information about Marker Test Diagnostics, visit

News Articles [1647 Associated News Articles listed on BioPortfolio]

2018 NTproBNP Test Volume and Sales Forecasts: US, Europe, Japan [Report Updated: 01011970] Prices from USD $750

This new report from VPGMarketResearch provides analysis of NTproBNP testing, including test volume and sales forecasts by country. Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USAList...

RPS Diagnostics receives updated CE Mark for FebriDx test

RPS Diagnostics can now launch the test in the European Union and all countries that recognize the CE mark. FebriDx is a simple to use POC test that The post RPS Diagnostics receives updated CE Mark ...

Zika screening test by Co-Diagnostics earns CE mark

Co-Diagnostics' Logix Smart Zika test received CE-IVD marking, permitting the assay's sale in European Union states and other -More- 

DiaSorin: USA, Europe, JapanSales, Market Shares and Competitive Position by Product [Report Updated: 01011970] Prices from USD $3500

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

C2N Diagnostics begins clinical study of brain amyloidosis blood test

The pivotal plasma test for amyloid risk screening (PARIS) study will assess and validate the clinical diagnostic performance of the C2N brain amyloidosis blood test. C2N test is The post C2N Diagnos...

Atomo Diagnostics Wins Approval For Australia’s First HIV Self-Test, And Secures WHO Endorsement

Atomo Diagnostics’ HIV Self Test has got the green light as Australia’s first HIV self-test and won approval from the...   

EU updates approval for rapid POC test from RPS Diagnostics

European regulators have granted RPS Diagnostics an updated CE mark approval for its rapid point-of-care test, called FebriDx -More- 

Co-Diagnostics receives CE mark for Logix Smart ZDC Test

The Logix Smart ZDC has entered into the markets, and is available for purchase from the company’s Utah-based facility. Co-Diagnostics said that the procurement of CE mark for the The post Co-Diag...

PubMed Articles [1653 Associated PubMed Articles listed on BioPortfolio]

Diagnostics of allergies with prick test.

We Have the Technology, but Should We Build the Test?

The refinement of leprosy PCR diagnostics by the amplification of specie-specific repeated fragment of the Mycobacterium leprae genome.

Certain level of new registered cases of leprosy in a number of endemic countries in the world, as well as growing rate of transboundary migratory flows, raise the issue of effective diagnosis of this...

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection.

Various recent studies have focused on analyzing tumor genetic material released into the blood stream, known as circulating tumor DNA (ctDNA). Herein, we describe current research on the application ...

Introduction to Special Issue on "Electromagnetic Technologies for Medical Diagnostics: Fundamental Issues, Clinical Applications and Perspectives".

The application of microwave technologies in medical imaging and diagnostics is an emerging topic within the electromagnetic (EM) engineering community [...].

Clinical Trials [3153 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy

Current study evaluates the use of the improved Basophil Activation Test (BAT) in the diagnostics of IgE-mediated allergy to antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs).

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

DIAgnostics for Multidrug Resistant Tuberculosis in Africa

Recent advances in molecular diagnostics of tuberculosis, especially the GeneXpert Mycobacterium tuberculosis/Rifampicin test have reduced the time to diagnose Rifampicin Resistant Tubercu...

Companies [1502 Associated Companies listed on BioPortfolio]

Marker Test Diagnostics

Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative oral marker for the drug testing market. Marker Test Diagnostics is currently conducting re...

Marker Test Diagnostics, Inc.

Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative urine marker for the drug testing market. Marker Test Diagnostics has completed research st...

NOW Diagnostics Inc.

NOW Diagnostics Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single ...

Epitope Diagnostics, Inc.

Epitope Diagnostics will launch its innovative fecal sample-based rapid immunoassy test platform during the AACC meeting. This novel fecal sample test system is so user-friendly that it protects both ...

Pathwork Diagnostics, Inc.

Pathwork Diagnostics, Inc., based in Redwood City, Calif., develops and commercializes high-value molecular diagnostics for oncology. The company's first test to market - the Pathwork(R) Tissue of Ori...

More Information about "Marker Test Diagnostics" on BioPortfolio

We have published hundreds of Marker Test Diagnostics news stories on BioPortfolio along with dozens of Marker Test Diagnostics Clinical Trials and PubMed Articles about Marker Test Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Marker Test Diagnostics Companies in our database. You can also find out about relevant Marker Test Diagnostics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Corporate Database Quicklinks

Searches Linking to this Company Record